NCT07385560

Brief Summary

This study aims to evaluate whether adding a fenestration procedure to standard ultrasound-guided aspiration and corticosteroid-lidocaine injection provides additional clinical benefits for patients with symptomatic Baker's cyst associated with knee osteoarthritis. Baker's cyst is a fluid-filled swelling located behind the knee that may cause pain, stiffness, swelling, and limited mobility. Although aspiration with medication injection is commonly used to relieve symptoms, recurrence of the cyst is frequent. Fenestration is a minimally invasive technique in which small controlled openings are created in the cyst wall under ultrasound guidance to improve internal drainage and potentially reduce recurrence. In this prospective, randomized, double-blind, controlled study, participants will be assigned to one of two groups:

  1. 1.aspiration with corticosteroid and lidocaine injection, or
  2. 2.aspiration with corticosteroid and lidocaine injection plus fenestration.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Feb 2026May 2026

First Submitted

Initial submission to the registry

January 22, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

February 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Last Updated

February 4, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

January 22, 2026

Last Update Submit

January 29, 2026

Conditions

Keywords

Baker's cystKnee osteoarthritisUltrasound-guided aspirationSteroid injectionLidocaineFenestrationOMERACTWOMACMusculoskeletal ultrasoundCyst recurrenceKOOS

Outcome Measures

Primary Outcomes (1)

  • Change in Baker's Cyst Volume

    Baker's cyst volume measured by ultrasonography using three-dimensional linear measurements (height × width × depth) and calculated in cubic millimeters (mm³). Volume measurements will be compared between the two study groups (Aspiration + Steroid-Lidocaine vs. Aspiration + Steroid-Lidocaine + Fenestration). All measurements will be performed by a blinded physician using a 7-13 MHz linear transducer. Lower values indicate a reduction in cyst size.

    Baseline, 2 weeks, 1 month, and 3 months after the intervention

Secondary Outcomes (9)

  • Change in Pain Severity (NRS Score)

    Baseline, 1 hour post-procedure, 2 weeks, 1 month, 3 months.

  • Change in Rauschning-Lindgren Classification (RLC)

    Baseline, 2 weeks, 1 month, 3 months.

  • Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Baseline, 2 weeks, 1 month, 3 months.

  • Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    Baseline, 2 weeks, 1 month, 3 months.

  • Baseline OMERACT Ultrasound Score

    Baseline

  • +4 more secondary outcomes

Other Outcomes (1)

  • Post-Procedure Pain Change (Short-Term Response)

    Baseline and 1 hour after the procedure.

Study Arms (2)

Aspiration + Steroid-Lidocaine

ACTIVE COMPARATOR

Ultrasound-guided aspiration of Baker's cyst followed by injection of corticosteroid and lidocaine mixture. No fenestration is performed.

Procedure: Baker's Cyst AspirationDrug: Steroid-Lidocaine Injection

Arm Title: Aspiration + Steroid-Lidocaine + Fenestration

EXPERIMENTAL

Ultrasound-guided aspiration followed by corticosteroid-lidocaine injection and fenestration using multiple needle perforations under real-time ultrasound guidance.

Procedure: Baker's Cyst AspirationDrug: Steroid-Lidocaine InjectionProcedure: Ultrasound-Guided Fenestration

Interventions

With the patient in the prone position, the ultrasound probe is placed transversely over the gastrocnemius-semimembranosus bursa. Under real-time ultrasound guidance, the needle is advanced while visualizing neurovascular structures to avoid injury. Aspiration of the cyst content is performed in all participants.

Arm Title: Aspiration + Steroid-Lidocaine + FenestrationAspiration + Steroid-Lidocaine

Following aspiration, an injection mixture consisting of 1 mL betamethasone, 1 mL of 2% lidocaine, and 1 mL of 0.9% isotonic sodium chloride is administered into the decompressed cyst cavity under ultrasound guidance.

Arm Title: Aspiration + Steroid-Lidocaine + FenestrationAspiration + Steroid-Lidocaine

After aspiration, fenestration of the cyst wall is performed under ultrasound guidance. The cyst wall is punctured at a minimum of six different points using a needle to create communication with surrounding tissues and reduce recurrence. Following fenestration, the same steroid and local anesthetic mixture is administered.

Arm Title: Aspiration + Steroid-Lidocaine + Fenestration

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 40 to 75 years
  • Diagnosis of knee osteoarthritis according to the 2010 American College of Rheumatology (ACR) criteria
  • Presence of a symptomatic Baker's cyst confirmed by ultrasonography
  • Ability to understand study procedures and provide written informed consent
  • Sufficient intellectual and social capacity to comply with study visits and follow-up requirements

You may not qualify if:

  • Presence of inflammatory arthritis, septic arthritis, crystal arthropathy, or secondary causes of knee osteoarthritis
  • Kellgren-Lawrence grade 4 knee osteoarthritis
  • Active systemic infection
  • History of malignancy
  • Intra-articular knee injection within the past 3 months
  • Knee trauma within the past 3 months
  • History of knee surgery
  • Contraindications to aspiration or corticosteroid injection (e.g., local infection, bleeding disorders, uncontrolled diabetes mellitus)
  • Requirement to continue medications for inflammatory arthritis
  • Diagnosed psychiatric disorder that may impair study participation
  • Use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the past 1 week
  • Physical therapy applied to the knee region within the past 1 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Istanbul, Istanbul, 34098, Turkey (Türkiye)

Location

Related Publications (10)

  • Kim JM, Kang S, Yoon JS. Association of complicated Baker's cysts with knee pathologies as compared to simple Baker's cysts. Medicine (Baltimore). 2024 Jun 7;103(23):e38407. doi: 10.1097/MD.0000000000038407.

    PMID: 38847688BACKGROUND
  • Mortada M, Amer YA, Zaghlol RS. Efficacy and Safety of Musculoskeletal Ultrasound Guided Aspiration and Intra-Lesional Corticosteroids Injection of Ruptured Baker's Cyst: A Retrospective Observational Study. Clin Med Insights Arthritis Musculoskelet Disord. 2020 Nov 10;13:1179544120967383. doi: 10.1177/1179544120967383. eCollection 2020.

    PMID: 33223862BACKGROUND
  • Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S208-28. doi: 10.1002/acr.20632. No abstract available.

    PMID: 22588746BACKGROUND
  • Ferdousi A, Islam MA, Begum M, Debnath MR, Shapla SP, Saha T, Biswas R, Ferdouse F, Rahman MA. Diagnostic Value of Ultrasonography in Determination of Knee Joint Pathologies with Comparison to MRI. Mymensingh Med J. 2024 Oct;33(4):989-995.

    PMID: 39351715BACKGROUND
  • Bandinelli F, Fedi R, Generini S, Porta F, Candelieri A, Mannoni A, Innocenti M, Matucci Cerinic M. Longitudinal ultrasound and clinical follow-up of Baker's cysts injection with steroids in knee osteoarthritis. Clin Rheumatol. 2012 Apr;31(4):727-31. doi: 10.1007/s10067-011-1909-9. Epub 2011 Dec 27.

    PMID: 22200813BACKGROUND
  • Chen CK, Lew HL, Liao RI. Ultrasound-guided diagnosis and aspiration of Baker's cyst. Am J Phys Med Rehabil. 2012 Nov;91(11):1002-4. doi: 10.1097/PHM.0b013e318269d95b. No abstract available.

    PMID: 22955026BACKGROUND
  • Oo WM, Linklater JM, Bennell KL, Pryke D, Yu S, Fu K, Wang X, Duong V, Hunter DJ. Are OMERACT Knee Osteoarthritis Ultrasound Scores Associated With Pain Severity, Other Symptoms, and Radiographic and Magnetic Resonance Imaging Findings? J Rheumatol. 2021 Feb;48(2):270-278. doi: 10.3899/jrheum.191291. Epub 2020 May 15.

    PMID: 32414954BACKGROUND
  • Acebes JC, Sanchez-Pernaute O, Diaz-Oca A, Herrero-Beaumont G. Ultrasonographic assessment of Baker's cysts after intra-articular corticosteroid injection in knee osteoarthritis. J Clin Ultrasound. 2006 Mar-Apr;34(3):113-7. doi: 10.1002/jcu.20210.

    PMID: 16547992BACKGROUND
  • Smith MK, Lesniak B, Baraga MG, Kaplan L, Jose J. Treatment of Popliteal (Baker) Cysts With Ultrasound-Guided Aspiration, Fenestration, and Injection: Long-term Follow-up. Sports Health. 2015 Sep-Oct;7(5):409-14. doi: 10.1177/1941738115585520. Epub 2015 May 5.

    PMID: 26502415BACKGROUND
  • Abate M, Di Carlo L, Di Iorio A, Salini V. Baker's Cyst with Knee Osteoarthritis: Clinical and Therapeutic Implications. Med Princ Pract. 2021;30(6):585-591. doi: 10.1159/000518792. Epub 2021 Aug 2.

    PMID: 34348320BACKGROUND

MeSH Terms

Conditions

Popliteal CystOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

Synovial CystCystsNeoplasmsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • TUTKU NAZ BULUT, MD

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

TUTKU NAZ BULUT, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
This is a double-blind study. Participants and investigators who perform evaluations are blinded to group assignment. The clinician performing the ultrasound-guided procedure is not involved in outcome assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: "Two-arm, parallel-group, randomized controlled interventional study evaluating the clinical effects of adding fenestration to ultrasound-guided aspiration."
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 22, 2026

First Posted

February 4, 2026

Study Start

February 15, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

May 30, 2026

Last Updated

February 4, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant-level data will not be shared. Study results will be reported in aggregated form in a manner that does not allow identification of individual participants.

Locations